Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Massive Bio

Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown
From Massive Bio
Via Business Wire
Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching
From Massive Bio
Via Business Wire
Massive Bio and Prognos Health Announce Strategic Partnership to Expand Oncology Access
From Massive Bio
Via Business Wire
MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant
From Massive Bio
Via Business Wire
Massive Bio Recognized in Two Key Categories on CB Insights’ AI Drug Research & Development Market Map
From Massive Bio
Via Business Wire
Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25
From Massive Bio
Via Business Wire
Massive Bio Receives CNIL Certification for GDPR Compliance
From Massive Bio
Via Business Wire
Massive Bio Stands Committed to Accelerating Cancer Research and Clinical Trial Access Amid NIH Funding Uncertainty
From Massive Bio
Via Business Wire
Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025
From Massive Bio
Via Business Wire
Massive Bio Launches Patient Connect to Personalize Access to Cancer Clinical Trials Globally
From Massive Bio
Via Business Wire
Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care
From Massive Bio
Via Business Wire
Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching
From Massive Bio
Via Business Wire
Massive Bio and Un Ensayo Para Mi Partner to Transform Oncology Clinical Trial Access and Deploy AI Technologies Across LATAM at #ASCO24
From Massive Bio
Via Business Wire
Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
From Massive Bio
Via Business Wire
Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
From Massive Bio
Via Business Wire
PCC and Massive Bio Validate Existing AI System in Groundbreaking and Largest Multi-Sponsor Clinical Trial Matching Study
From Massive Bio
Via Business Wire
Massive Bio Unveils Groundbreaking Oncology/Hematology AI Platform at ASCO 2024: Revolutionizing Oncology/Hematology with AI Driven Personalized Insights for Clinical Trial Accessibility
From Massive Bio
Via Business Wire
Trialbee and Massive Bio Join Forces to Improve Clinical Trial Access and Patient Recruitment for Oncology and Hematology
From Massive Bio
Via Business Wire
Further Group Collaborates with Massive Bio, Integrating Health Solutions for the Insurance Industry to Boost Access to Cancer Clinical Trials Globally
From Massive Bio
Via Business Wire
Massive Bio Partners with Asklepieia, BeStrong, and Open Health Alliance in Greece to Enhance Cancer Clinical Trial
From Massive Bio
Via Business Wire
Massive Bio and CureMatch Announce Groundbreaking Partnership to Revolutionize Cancer Treatment through AI and Clinical Trial Accessibility
From Massive Bio
Via Business Wire
Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care
From Massive Bio
Via Business Wire
Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research
From Massive Bio
Via Business Wire
Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical Trial Matching for Cancer Patients Worldwide
From Massive Bio
Via Business Wire
Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform at ASCO 2023 to Simplify and Expand Access to Oncology Clinical Trials
From Massive Bio
Via Business Wire
Massive Bio Accelerates Its Expansion in the European Union, Driven by New Clinical Trials Regulations
From Massive Bio
Via Business Wire
Clinical Trials Demystified by Massive Bio’s Chief Medical Officer
From Massive Bio
Via Business Wire
Massive Bio is named to the New York City Digital Health 100
From Massive Bio
Via Business Wire
Massive Bio Announces Plans to Expand AI Use in Oncology, from Clinical Trial Matching to Drug Matching and Beyond
From Massive Bio
Via Business Wire
Massive Bio Reaffirms Global Growth Strategy with Key C-Suite Hires and Executive Director Appointments
From Massive Bio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.